Welcome
- Overview
- Faculty Profiles and Interests
- Support Personnel
- Laboratory Facilities
- NEWS & Announcements
- 2009-2010 Seminar Series
- 2010-2011 Seminar Series
- 2011-2012 Seminar Series
- Graduate Programs
- Current Students
- Student-Faculty Publications
- Recruitment
Rocket Science
About UT - Map to UT Health Science Campus
Related Links
- Cancer Biology Track
- 2011 Midwest DNA Symposium
- 2011 Graduate Research Forum
- 2010 Graduate Research Forum
- 2010 UT-COM Research Day
- Cancer Center
- Electron Microscopy Facility
- Flow Cytometry Core Lab
- Genomics Core Lab
- Advanced Microscopy & Imaging Center
Contact Us
Health Science Campus, Mail Stop #1010
3000 Arlington Avenue
Toledo, OH 43614
419-383-4131 phone
419-383-6228 fax
William A. Maltese, Ph.D.
![]() |
William Anthony Maltese, Ph.D. Professor and Chairman Biochemistry and Cancer Biology william.maltese@utoledo.edu |
RESEARCH INTERESTS:
Current research centers on the roles of Ras-related GTPases in intracellular trafficking and signaling pathways that regulate
unconventional forms of cell death. Recent studies have established that activated forms of the Ras oncogene trigger a form
of non-apoptotic cell death instead of cell proliferation in glioblastoma cells. This novel form of cell death, termed “methuosis”,
involves severe cytoplasmic vacuolization that begins with hyperstimulation of macropinocytosis (vesicular uptake of extracellular
fluid) and disruptions of endocytic trafficking. The Rac1 and Arf6 GTPases have been identified as key downstream mediators
of this novel effect of Ras. Current studies focus on further defining the molecular mechanisms underlying methuosis, and
determining if manipulation of the relevant pathways can be exploited in a therapeutic context to impede the growth of gliomas
and breast carcinomas in vivo. In this regard, unique chemical compounds related to a class of molecules termed chalcones
have been found to stimulate a methuosis phenotype similar to that caused by activated Ras. Ongoing studies are aimed at modifying
the structures of these molecules to optimize their potency and stability, with the long range goal of evaluating their therapeutic
potential in tumor models. A major objective is to identify the molecular targets of the methuosis-inducing compounds. Collaborations
have also been established with experts in bioengineering and nanoparticle development to explore the possibility of packaging
the new compounds in nanoparticles containing tumor-homing peptides. The goal of these studies is to promote tumor-specific
uptake of the drugs in brain tumors and breast cancers while minimizing toxicity to normal tissues.
Member of the mentoring faculty for the Biomedical Sciences Graduate Program (Cancer Biology track)
EDUCATION:
Ph.D. 1977 Syracuse University, Syracuse, NY
B.S. 1972 St. Francis College, Brooklyn, NY
RECENT ACADEMIC APPOINTMENTS:
1999-present Professor and Chairman, Biochemistry & Cancer Biology, University of Toledo Health Science Campus (formerly Medical
University of Ohio)
1997-1999 Professor of Cellular & Molecular Physiology, Penn. State University, College of Medicine
1996-1997 Senior Scientist Geisinger Clinic, Weis Center for Research
1987-1995 Staff Scientist Geisinger Clinic, Weis Center for Research
1981-1987 Assistant Professor of Neurology, Columbia University, College of Physicians & Surgeons
1980-1981 Research Assistant Professor of Pediatrics, Washington University, College of Medicine
1977-1979 Postdoctoral Trainee, Washington University, College of Medicine
RECENT PUBLICATIONS:
Wilson, E.N., Bristol, M.D., Di, X.L., Maltese, W.A., Koterba, K., Beckman, M.J. and Gewirtz, D.A. (2011) A switch between
cytoprotective and cytotoxic autophagy in the radiosensitization of breast tumor cells by chloroquine and vitamin D. Hormones Cancer 2:272-285. http://www.springerlink.com/content/h7pt2p13jpw01671/fulltext.pdf
Overmeyer, J.H., Young, A.M., Bhanot, H. and Maltese, W.A. (2011) A Chalcone-related small molecule that induces methuosis, a novel form of non-apoptotic cell death, in glioblastoma cells. Mol. Cancer 10:69.
Overmeyer, J.H., and Maltese, W.A. (2011) Death pathways triggered by activated Ras in cancer cells. Frontiers Biosci. 16:1693-1713.
Bhanot, H., Young, A.M., Overmeyer, J.H. and Maltese, W.A. (2010) Induction of nonapoptotic cell death by activated Ras requires inverse regulation of Rac1 and Arf6. Mol. Cancer Res. 8:1358-1374.
Kaul, A., and Maltese, W.A. (2009) Killing of cancer cells by the photoactivatable protein kinase C inhibitor, calphostin C, involves induction of endoplasmic
reticulum stress. Neoplasia 11:823-834.
Alam, G., Cui, H., Shi, H., Yang, L., Ding, J., Mao, L., Maltese, W.A. and Ding, H-F. (2009) MYCN promotes the expansion of Phox2B-positive neuronal progenitors to drive neuroblastoma development. Am. J. Path.175:856-866.
Overmeyer, J.H., Kaul, A., Johnson, E.E., and Maltese, W.A. (2008) Active Ras triggers death in glioblastoma cells through hyperstimulation of macropinocytosis. Mol. Cancer Res.6:965-977.
Kaul, A., Overmeyer, J.H., and Maltese, W.A. (2007) Activated Ras induces cytoplasmic vacuolation and non-apoptotic cell death in glioblastoma cells via novel effector pathways. Cell. Signalling19:1034-1043.
Johnson, E.E., Overmeyer, J.H., Gunning, W.T. and Maltese, W.A. (2006) Gene silencing reveals a specific function of hVps34 phosphatidylinositol 3-kinase in late versus early endosomes. J. Cell Sci.119:1219-1232.
Zeng, X., Overmeyer, J.H., and Maltese, W.A. (2006) Functional specificity of the mammalian Beclin-Vps34 PI 3-Kinase complex in macroautophagy versus endocytosis and lysosomal enzyme trafficking. J. Cell Sci.119:259-270.
Overmeyer, J.H., and Maltese, W.A. (2005) Tyrosine phosphorylation of Rab proteins. Methods in Enzymology403:194-202.
Ding, J.D., Soule, G., Overmeyer, J.H., and Maltese, W.A. (2003) Tyrosine phosphorylation of the Rab24 GTPase in cultured mammalian cells. Biochem. Biophys. Res. Commun.312:670-675.
Maltese, W.A., Soule, G., Gunning, W., Calomeni, E. and Alexander, B. (2002) Mutant Rab24 GTPase is targeted to nuclear inclusions. BMC Cell Biology3:25-42.
Overmeyer, J.H., Wilson, A.L., and Maltese, W.A. (2001) Membrane targeting of a Rab GTPase that fails to associate with Rab escort protein (REP) or guanine nucleotide dissociation
inhibitor. J. Biol. Chem.276:20379-20386.
Maltese, W.A., Wilson, S., Tan, Y., Suomensaari, S., Sinha, S., Barbour, R., and McConlogure, L. (2001) Retention of the Alzheimer's beta-amyloid precursor protein fragment C99 in the endoplasmic reticulum prevents formation of
the amyloid beta-peptide. J. Biol. Chem.276:20267-20279.
Erdman, R.A., and Maltese, W.A. (2001) Different Rab GTPases associate preferentially with alpha or beta GDP-dissociation inhibitors. Biochem. Biophys. Res. Commun.282:4-9.
Erdman, R.A., Shellenberger, K.E., Overmeyer, J.H., and Maltese, W.A. (2000) Rab24 is an atypical member of the Rab GTPase family. J. Biol. Chem.275:3848-3856.
UT Virtual View Book
UT Rockets
Let Us Share More About UT!
UTMC Named Regions #1 Hospital
